The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

J. W. Smith, W. J. Urba, B. D. Curti, L. J. Elwood, R. G. Steis, J. E. Janik, W. H. Sharfman, L. L. Miller, R. G. Fenton, K. C. Conlon, M. Sznol, S. P. Creekmore, N. F. Wells, F. W. Ruscetti, J. R. Keller, K. Hestdal, M. Shimizu, J. Rossio, W. G. Alvord

Research output: Contribution to journalArticlepeer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences